Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Scher

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancerM Rosenstein, J Armstrong, M Kris, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1994
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancerD G Pfister, D Bajorin, R Motzer, et al.
Cancer|March 26, 1999
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
Cancer Investigation|October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancerP M Dodd, J A McCaffrey, M Mazumdar, et al.
Investigational New Drugs|February 1, 1993
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancerD G Pfister, D Bajorin, R J Motzer, et al.
Progress in Clinical and Biological Research|January 1, 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservationH Scher, H Herr, C Sternberg, et al.
British Journal of Urology|September 1, 1989
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimenH Scher, H Herr, C Sternberg, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology ProgramC N Sternberg, A Yagoda, H Scher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 5, 2006
An electrodiagnostic evaluation of the effect of pre-existing peripheral nervous system disorders in patients treated with the novel proteasome inhibitor bortezomibM D Stubblefield, S Slovin, B MacGregor-Cortelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancerI Osman, H Scher, Z F Zhang, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancerM Rosenstein, J Armstrong, M Kris, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1994
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancerD G Pfister, D Bajorin, R Motzer, et al.
Cancer|March 26, 1999
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
Cancer Investigation|October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancerP M Dodd, J A McCaffrey, M Mazumdar, et al.
Investigational New Drugs|February 1, 1993
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancerD G Pfister, D Bajorin, R J Motzer, et al.
Progress in Clinical and Biological Research|January 1, 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservationH Scher, H Herr, C Sternberg, et al.
British Journal of Urology|September 1, 1989
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimenH Scher, H Herr, C Sternberg, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology ProgramC N Sternberg, A Yagoda, H Scher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 5, 2006
An electrodiagnostic evaluation of the effect of pre-existing peripheral nervous system disorders in patients treated with the novel proteasome inhibitor bortezomibM D Stubblefield, S Slovin, B MacGregor-Cortelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancerI Osman, H Scher, Z F Zhang, et al.
Pageof 8